Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2042567

Cover Image

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2042567

Aspiration & Biopsy Needles Market, By Product, By Target Organ, By Procedure, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

PUBLISHED:
PAGES: 376 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3250
PDF (5 User License)
USD 4650
PDF & Excel (Enterprise User License)
USD 5650

Add to Cart

Aspiration & Biopsy Needles Market size was valued at US$ 1,168.83 Million in 2025, expanding at a CAGR of 5.44% from 2026 to 2033.

An aspiration and biopsy needle is a medical tool used to collect fluid, cells, or tissue samples for testing. Aspiration uses a thin needle for fluids or cells, while a biopsy removes small tissue pieces. These procedures help examine abnormal areas without major surgery and are typically quick, minimally invasive, and often guided by imaging for better accuracy and patient comfort.

From a broader perspective, the use of these needles is closely linked to national health priorities around early diagnosis. As mentioned by the National Cancer Institute of the United States, cancer continues to be among the leading diagnoses, with over 1.9 million people being affected annually and undergoing a biopsy to confirm their diagnosis. Likewise, the World Health Organization has indicated that cancer kills almost 10 million people every year worldwide, thus calling for improved screening and diagnosis. The increasing attention being given to early detection by institutions is facilitating the routine use of minimally invasive biopsies in clinical settings.

Aspiration & Biopsy Needles Market- Market Dynamics

➤ Rising Cancer Burden and Early Detection Initiatives to Support Market Demand

The increasing number of cancer cases is encouraging healthcare systems to strengthen early diagnosis practices, where aspiration and biopsy needles are routinely used for confirmation. According to WHO, cancer is responsible for more than 9 million deaths per annum, prompting most countries to develop screening programs for diseases of the breast, cervix, and lungs. Screening programs make use of minimal-invasion biopsies to confirm abnormalities discovered during primary screenings.

On a similar note, corporations like the Fujifilm Holdings Corporation have indicated their continued involvement in diagnostics and healthcare through the reporting of their yearly results, which helps in forming the pathways that aid in early detection. The combination of efforts by public health institutions and innovations in corporate industries is making significant contributions towards the achievement of early diagnosis. With increasing awareness about early detection, accurate biopsy technologies have gained wide acceptance.

Aspiration & Biopsy Needles Market- Segmentation Analysis:

The Global Aspiration & Biopsy Needles Market is segmented on the basis of Product, Target Organ, Procedure, End User, and Region.

By targeted organ, the market is segmented into eight categories, with the breast segment expected to hold a meaningful position due to the structured nature of screening and diagnosis practices. Many health programs around the world focus on the early detection of breast cancer. According to the World Health Organization, breast cancer is the most commonly occurring cancer across the globe, thus recommending screening programs that usually involve biopsy for confirmation. Core needle biopsy is one of the procedures widely conducted after mammograms. From the perspective of the companies, Hologic Inc. was able to generate revenues of approximately $5.4 billion in 2023, a substantial share of which is due to the breast health solution market, which includes biopsy systems. These findings suggest that considerable effort continues to be directed at enhancing the diagnostic process.

In terms of procedure, Image-guided procedures are expected to remain influential in the market because they help clinicians locate targeted tissue more precisely, reducing repeat attempts and patient discomfort. Public healthcare systems increasingly support such techniques; for instance, the National Health Service highlights the use of ultrasound and CT guidance for accurate biopsy sampling in routine care. This approach is particularly useful in complex organs where visual confirmation improves confidence during procedures. Becton, Dickinson and Company, on their part, recorded total sales of approximately $20.2 billion for the year 2023 and continues to emphasize interventions and diagnostics, among which are biopsy devices that work well with image-guided procedures. The synergy of such a system makes reliable usage possible. With increasing emphasis on efficiency and accuracy in clinics, image-guided biopsy is bound to be relied upon.

Aspiration & Biopsy Needles Market- Geographical Insights

The regional perspective of aspiration and biopsy needles highlights variations in healthcare access and diagnostic practices. In North America, structured screening systems and strong clinical infrastructure support steady usage of biopsy procedures. According to the National Cancer Institute, around 1.9 million new cancer cases are diagnosed annually in the United States, many requiring tissue confirmations. Moreover, the nation also conducts millions of biopsies every year, with a huge percentage involving the use of needles since they are minimally invasive. Such companies as Becton, Dickinson and Company recorded revenues totaling around $20.2 billion in 2023 due to their continuous investments in diagnostic and interventional technologies. This combination of institutional screening support and company-level innovation sustains consistent procedural volumes in the region.

On the other hand, the Asia-Pacific area is projected to hold a significant share due to increasing awareness and accessibility in healthcare. According to the International Agency for Research on Cancer, about half of the world's cancers are found in Asia, forming an ample pool of patients who need diagnosis. In countries like India and China, governments have been enhancing the availability of diagnostic facilities and patient screening programs. In the industry context, corporations such as Medtronic plc have been continuously increasing their presence and technological utilization within developing health systems, which has been shown in their regional news releases. Growing access to imaging equipment and professionals will eventually enable the use of less invasive biopsies. The trend indicates that there is a clear path, whereby the growing health systems and awareness promote such medical procedures' utilization.

Canada Aspiration & Biopsy Needles Market- Country Insights

Canada's healthcare environment reflects a structured and data-driven approach to cancer diagnosis, which supports the use of aspiration and biopsy needles in routine practice. The Government of Canada highlights that cancer remains a major health concern, with more than 200,000 Canadians diagnosed annually, and it is a primary cause of death in the country. Also, according to the Canadian Cancer Society, about 2 out of 5 Canadians will get cancer throughout their lives, thus creating the need for diagnosis through methods like biopsy by needles. Regarding the business organization, Becton, Dickinson, and Company earned revenues of around $20.2 billion in 2023, indicating their continuous involvement in diagnostic and interventional tools used in such practices. These examples highlight the role of Canada's health care system, which emphasizes early diagnosis, through its clinical capabilities and business organization involvement, in the regular use of biopsies.

Aspiration & Biopsy Needles Market- Competitive Landscape:

The aspiration and biopsy needle sector reflects a balanced mix of global manufacturers and regional suppliers, creating a competitive yet structured environment. Companies such as Becton, Dickinson and Company, Hologic Inc., Cook Medical, and Argon Medical Devices distribute their products through hospitals, clinical networks, and specialized distributors. Competition is shaped by product reliability, procedural ease, technological compatibility with imaging systems, and availability, while companies also focus on training support and service networks to strengthen their presence.

In recent developments, companies continue to refine their portfolios through innovation and collaboration. For example, in 2025, Argon Medical Devices, Inc., expanded its product line of soft tissue biopsy devices, with special focus on minimally invasive devices that aid precision sampling and usability. Besides this, companies are engaging in research & development, ergonomic advancements, and extending their reach via collaborations. Such initiatives indicate a consistent strategy that is allowing innovation and access to determine participation.

Recent Developments:

In December 2025, companies such as Boston Scientific Corporation and Hologic Inc. expanded their biopsy technology portfolios, focusing on precision, safety, and minimally invasive capabilities, including advancements in image-guided and vacuum-assisted biopsy systems. This development reflects ongoing efforts to improve diagnostic accuracy and support wider clinical adoption of minimally invasive cancer detection procedures. These advancements strengthen minimally invasive diagnostics by improving precision, safety, and efficiency, supporting broader clinical adoption and better patient outcomes globally.

In January 2026, Medtronic plc and Becton Dickinson and Company continued expanding their portfolios of semi-automatic core biopsy instruments to support minimally invasive diagnostics. These developments focus on improving ease of use and precision in tissue collection, aligning with increasing clinical demand for efficient biopsy procedures across healthcare systems. These advancements improve procedural accuracy and usability, supporting efficient diagnostics and reinforcing the role of minimally invasive biopsy solutions in modern healthcare systems.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ASPIRATION & BIOPSY NEEDLES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Argon Medical Devices, Inc.
  • B. Braun SE
  • Becton, Dickinson and Company (BD)
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • CONMED Corporation
  • Cook Group Incorporated
  • Danaher Corporation (Leica Biosystems)
  • Dr. Japan Co., Ltd.
  • Fujifilm Holdings Corporation
  • HAKKO CO., LTD.
  • Hologic, Inc.
  • INRAD, Inc.
  • Iscon Surgicals Ltd.
  • Johnson & Johnson (Ethicon)
  • Medax S.r.l. Unipersonale
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Olympus Corporation
  • Pajunk GmbH
  • Ranfac Corp.
  • Remington Medical, Inc.
  • Somatex Medical Technologies GmbH
  • Sterylab S.r.l.
  • Stryker Corporation
  • Others

GLOBAL ASPIRATION & BIOPSY NEEDLES MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033

  • Automated Biopsy Needles
  • Semi-Automated Biopsy Needles
  • Fine Needle Aspiration Biopsy (FNAB)
  • Core Needle Biopsy (CNB)
  • Vacuum Assisted Biopsy (VAB)

GLOBAL ASPIRATION & BIOPSY NEEDLES MARKET, BY TARGET ORGAN- MARKET ANALYSIS, 2020 - 2033

  • Breast
  • Lung
  • Colorectal
  • Prostate
  • Kidney
  • Bone & Bone Marrow
  • Liver
  • Thyroid
  • Others

GLOBAL ASPIRATION & BIOPSY NEEDLES MARKET, BY PROCEDURE- MARKET ANALYSIS, 2020 - 2033

  • Image-guided Procedures
  • Ultrasound-Guided Biopsy
  • Stereotactic-Guided Biopsy
  • MRI-Guided Biopsy
  • CT-Guided Biopsy
  • Other Image-Guided Procedure
  • Non-image-guided Procedures

GLOBAL ASPIRATION & BIOPSY NEEDLES MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Hospitals & Surgical Centers
  • Diagnostic Clinics & Pathology Laboratories
  • Ambulatory Care Centers
  • Research & Academic Institutes
  • Cancer Research Centers
  • Others

GLOBAL ASPIRATION & BIOPSY NEEDLES MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA
Product Code: ANV6476

Table of Contents

1. Aspiration & Biopsy Needles Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Aspiration & Biopsy Needles Market Snippet by Product
    • 2.1.2. Aspiration & Biopsy Needles Market Snippet by Target Organ
    • 2.1.3. Aspiration & Biopsy Needles Market Snippet by Procedure
    • 2.1.4. Aspiration & Biopsy Needles Market Snippet by End User
    • 2.1.5. Aspiration & Biopsy Needles Market Snippet by Country
    • 2.1.6. Aspiration & Biopsy Needles Market Snippet by Region
  • 2.2. Competitive Insights

3. Aspiration & Biopsy Needles Key Market Trends

  • 3.1. Aspiration & Biopsy Needles Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Aspiration & Biopsy Needles Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Aspiration & Biopsy Needles Market Opportunities
  • 3.4. Aspiration & Biopsy Needles Market Future Trends

4. Aspiration & Biopsy Needles Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Aspiration & Biopsy Needles Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Aspiration & Biopsy Needles Market Landscape

  • 6.1. Aspiration & Biopsy Needles Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Aspiration & Biopsy Needles Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
    • 7.1.2. Automated Biopsy Needles
    • 7.1.3. Semi-Automated Biopsy Needles
    • 7.1.4. Fine Needle Aspiration Biopsy (FNAB)
    • 7.1.5. Core Needle Biopsy (CNB)
    • 7.1.6. Vacuum Assisted Biopsy (VAB)

8. Aspiration & Biopsy Needles Market - By Target Organ

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Target Organ, 2025 & 2033 (%)
    • 8.1.2. Breast
    • 8.1.3. Lung
    • 8.1.4. Colorectal
    • 8.1.5. Prostate
    • 8.1.6. Kidney
    • 8.1.7. Bone & Bone Marrow
    • 8.1.8. Liver
    • 8.1.9. Thyroid
    • 8.1.10. Others

9. Aspiration & Biopsy Needles Market - By Procedure

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Procedure, 2025 & 2033 (%)
    • 9.1.2. Image-guided Procedures
      • 9.1.2.1. Ultrasound-Guided Biopsy
      • 9.1.2.2. Stereotactic-Guided Biopsy
      • 9.1.2.3. MRI-Guided Biopsy
      • 9.1.2.4. CT-Guided Biopsy
      • 9.1.2.5. Other Image-Guided Procedure
    • 9.1.3. Non-image-guided Procedures

10. Aspiration & Biopsy Needles Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 10.1.2. Hospitals & Surgical Centers
    • 10.1.3. Diagnostic Clinics & Pathology Laboratories
    • 10.1.4. Ambulatory Care Centers
    • 10.1.5. Research & Academic Institutes
    • 10.1.6. Cancer Research Centers
    • 10.1.7. Others

11. Aspiration & Biopsy Needles Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Aspiration & Biopsy Needles Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Aspiration & Biopsy Needles Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.17. Denmark
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Denmark Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Denmark Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.18. Rest of Europe
      • 11.3.18.1. Overview
      • 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.18.3. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.18.4. Rest of the Europe Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.3.18.5. Rest of the Europe Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Aspiration & Biopsy Needles Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.16. Taiwan
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Taiwan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Taiwan Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Taiwan Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.17. Vietnam
      • 11.4.17.1. Overview
      • 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.17.3. Vietnam Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.17.4. Vietnam Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.4.17.5. Vietnam Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.18. Rest of APAC
      • 11.4.18.1. Overview
      • 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.18.3. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.18.4. Rest of APAC Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.4.18.5. Rest of APAC Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Aspiration & Biopsy Needles Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Aspiration & Biopsy Needles Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.14. Iran
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Iran Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Iran Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Iran Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.15. Qatar
      • 11.6.15.1. Overview
      • 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.15.3. Qatar Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.15.4. Qatar Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.6.15.5. Qatar Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.16. Rest of MEA
      • 11.6.16.1. Overview
      • 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.16.3. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.16.4. Rest of MEA Market Size and Forecast, By Target Organ, 2020 - 2033 (US$ Million)
      • 11.6.16.5. Rest of MEA Market Size and Forecast, By Procedure, 2020 - 2033 (US$ Million)
      • 11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Aspiration & Biopsy Needles Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Argon Medical Devices, Inc.
    • 12.2.2. B. Braun SE
    • 12.2.3. Becton, Dickinson and Company (BD)
    • 12.2.4. Boston Scientific Corporation
    • 12.2.5. Cardinal Health, Inc.
    • 12.2.6. CONMED Corporation
    • 12.2.7. Cook Group Incorporated
    • 12.2.8. Danaher Corporation (Leica Biosystems)
    • 12.2.9. Dr. Japan Co., Ltd.
    • 12.2.10. Fujifilm Holdings Corporation
    • 12.2.11. HAKKO CO., LTD.
    • 12.2.12. Hologic, Inc.
    • 12.2.13. INRAD, Inc.
    • 12.2.14. Iscon Surgicals Ltd.
    • 12.2.15. Johnson & Johnson (Ethicon)
    • 12.2.16. Medax S.r.l. Unipersonale
    • 12.2.17. Medtronic plc
    • 12.2.18. Merit Medical Systems, Inc.
    • 12.2.19. Olympus Corporation
    • 12.2.20. Pajunk GmbH
    • 12.2.21. Ranfac Corp.
    • 12.2.22. Remington Medical, Inc.
    • 12.2.23. Somatex Medical Technologies GmbH
    • 12.2.24. Sterylab S.r.l.
    • 12.2.25. Stryker Corporation
    • 12.2.26. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!